Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Simple probe press after prostate biopsy may cut bleeding and infection

NCT ID NCT07550985

Symptom relief Sponsor: Veterans Health Service Medical Center, Seoul, Korea Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 28, 2026 · Updated 2 times

Summary

This study tests whether pressing the ultrasound probe against the prostate for a short time after a biopsy can reduce bleeding and infection. About 324 men having their first prostate biopsy will be randomly assigned to receive probe compression or not. The goal is to see if this simple step lowers the chance of blood in urine or stool, and related infections.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 324 people

The number the study aims to enrol. It can still change while the study runs.

Started

Mar 2026

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Male participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Male patients aged ≥18 years * Scheduled to undergo transrectal ultrasound-guided prostate biopsy * Biopsy-naïve patients (first-time prostate biopsy) * Able to provide written informed consent Exclusion Criteria: * Uncorrectable coagulopathy or bleeding disorder * Active urinary tract infection at the time of biopsy * Acute anorectal conditions (e.g., hemorrhoidal bleeding, anal fissure, proctitis) * Inability to discontinue or appropriately manage anticoagulant or antiplatelet therapy * History of severe drug allergy or hypersensitivity to medications used in the study * Individuals unable to provide informed consent (e.g., cognitive impairment, medically incapacitated) or other vulnerable populations * Participation in another interventional study related to prostate disease that may interfere with the outcomes of this study * Severe comorbid conditions limiting study participation * Inability to comply with follow-up procedures

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Post biopsy bleeding are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Post biopsy bleeding Prostate biopsy Transrectal ultrasound-guided prostate biopsy

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • VHS medical center

    RECRUITING

    Seoul, Seoul, 05368, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.